𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Elucidation of the role of hydrophobic bonding in influencing intestinal absorption of model sulfonamides and revealing possible mechanism of drug absorption in rat model

✍ Scribed by San-Laung Chow; Janardan B. Nagwekar


Publisher
John Wiley and Sons
Year
1993
Tongue
English
Weight
775 KB
Volume
82
Category
Article
ISSN
0022-3549

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Factors influencing regional differences
✍ Amal Kaddoumi; David Fleisher; Tycho Heimbach; Lilian Y. Li; Susan Cole πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 188 KB

The objective of this study was to evaluate potential contributions of intestinal export and metabolism to the oral dose-dependent pharmacokinetics of the human cGMP-specific phosphodiesterase type 5 inhibitor, UK-343,664. Differences between jejunal and ileal handling of this CYP3A and P-gp substra

Absorption barriers in the rat intestina
✍ Daniel R. Mudra; Jin Y. Jin; Ronald T. Borchardt πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 528 KB

The absorption of drug molecules is often investigated using in vitro or in situ models of the intestinal mucosa; however, few studies have quantified the kinetics that limit absorption. The objective of this study was to quantify kinetic rates of rat intestinal absorption, metabolism, and efflux us

Pharmacokinetics of pafenolol in the rat
✍ Hans Lenneras; Carl G. RegΓ₯rdh πŸ“‚ Article πŸ“… 1990 πŸ› John Wiley and Sons 🌐 English βš– 559 KB

The pharmacokinetics of pafenolol, a highly selective /?,-adrenoceptor antagonist, have been studied in starved and unstarved rats. Separate groups received intravenous doses (0.3 and 3.0pmol kg-I) and oral doses (1 and 25pmol kg-I). The systemic clearance of pafenolol was constant in the dose range

Absorption barriers in the rat intestina
✍ Daniel R. Mudra; Ronald T. Borchardt πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 457 KB πŸ‘ 1 views

Modulation of intestinal drug absorption barriers can have a profound impact on the bioavailability of orally administered compounds. With its commonality of use as an absorption model, it is valuable to assess the role of such barriers in the rat intestinal mucosa. In the present study, atenolol an